Company news

Guangyuyuan Chinese Herbal Medicine Co., Ltd. Class A (SSE:600771) news

Guangyuyuan Chinese Herbal Medicine Co., Ltd. Class A news releases on 6ix. Latest, Sep 11, 2026: "Guangyuyuan Chinese Herbal Medicine Co., Ltd."Announcement…

Guangyuyuan Chinese Herbal Medicine Co., Ltd. Class A (SSE:600771) news

Press releases & updates

"Guangyuyuan Chinese Herbal Medicine Co., Ltd."Announcement on Resignation of the Securities Affairs Representative

"Guangyuyuan Chinese Herbal Medicine Co., Ltd."Pre-announcement on Convening the 2026 Semi-annual Performance Briefing

"Guangyuyuan Chinese Herbal Medicine Co., Ltd."Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors

"Guangyuyuan Chinese Herbal Medicine Co., Ltd."Announcement on Notifying Creditors Regarding the Use of Capital Reserve to Offset Losses

"Guangyuyuan Chinese Herbal Medicine Co., Ltd."Announcement on Progress in Major Litigation

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on a Product Being Selected as a Winning Bid in the National Centralized Volume-based Procurement of Chinese Patent Medicine Alliance

Announcement on Resolutions of the 4th Meeting of the 9th Board of Directors

Announcement on Change of Drug Production License of Holding Subsidiary

Announcement on Implementation Result of Shares Repurchase and Share Changes

Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Shanxi Jurisdiction in 2026 and Annual Report Performance Briefing

Announcement on Progress in Major Litigation

Announcement on Progress in Repurchasing Shares

Indicative Announcement on Completion of the Industrial and Commercial Change Registration Regarding the Reduction in Ownership Layers Between the Controlling Shareholder and the Actual Controller

Announcement on the Remuneration Plan for Directors in 2026

Announcement on Results of Shareholding Increase by Some Directors and Senior Management Members

Announcement on Progress in Initially Repurchasing Shares through Call Auction and Results of Share Repurchase

Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase

Announcement on Plan for Repurchasing Shares through Call Auction

Announcement on the Remuneration Plan for Senior Management Members in 2026

Announcement on Election of Employee Representative Director for the 9th Board of Directors

Announcement on Resolutions of the 20th Meeting of the 8th Board of Directors

Announcement on the Resolutions of the 19th Meeting of the 8th Board of Directors and the Appointment of Vice Presidents

Indicative Announcement on Postponing Term Change of the Board of Directors and Term Expiration of Partial Independent Directors

Announcement on Holding Subsidiary Receiving Registration Certificate for Chinese Patent Medicines in Macao

Announcement on Holding Subsidiary Obtaining Drug Registration Certificate

Indicative Announcement on the Reduction of Ownership Layers Between the Controlling Shareholder and the Actual Controller

Announcement on Resignation of Vice President

Announcement on Resolutions of the 18th Meeting of the 8th Board of Directors

Announcement on the Payment of Taxes and Late Fees by a Holding Subsidiary

Announcement on the Completion of the Share Increase Plan for Controlling Shareholders and Results of Shareholding Increase

Announcement on Resolutions of the 16th Meeting of the 8th Board of Directors

Announcement on Wholly-owned Subsidiary Receiving Government Subsidies

Announcement on Resolution of the 2024 Annual General Meeting

Announcement on Canceling the Board of Supervisors and Amending the Articles of Association and Related Systems

Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Shanxi Jurisdiction in 2025 and Annual Report Performance Briefing

Announcement on Resolution of the 11th Meeting of the 8th Board of Supervisors

Announcement on Resolution of the 13th Meeting of the 8th Board of Directors

Indicative Announcement on Changes in Controlling Shareholders's Equity

Announcement on Progress in Significant Litigation

Forecast Announcement on Convening the Q3 2024 Performance Briefing

Announcement on Resolution of the 12th Meeting of the 8th Board of Directors

Forecast Announcement on Convening Semi-annual Performance Briefing 2024

Announcement on Resolutions of 11th Meeting of the 8th Board of Directors

Announcement on Resolutions of 2023 Annual General Meeting

Announcement on Progress in Performance Commitment Matters of Underlying Company in Previous Major Asset Reorganization and Major Litigation

Announcement on Reply to Letter of Supervision on Information Disclosure of 2023 Annual Report from SSE

Announcement on Resolutions of 10th Session of 8th Board of Directors

Announcement on Receiving Government Subsidies by Subsidiaries

Announcement on Attending Online Collective Reception Day for Investors and Annual Report Performance Meeting of Listed Companies in Shanxi Jurisdiction in 2024